[Invasive fungal infection in solid organ transplant]

Enferm Infecc Microbiol Clin. 2012 Dec;30(10):645-53. doi: 10.1016/j.eimc.2012.09.004. Epub 2012 Nov 3.
[Article in Spanish]

Abstract

Invasive fungal infections (IFI) represent a serious threat for patients undergoing solid organ transplantation (SOT). IFI in SOT has a significant incidence and mortality not due to negligence. The management of IFI in SOT involves specific recommendations and has been individualized to the type of transplant and patient. The current review presents an overview of epidemiology, diagnosis, treatment and prevention of IFI in TOS. Depending on risk factors for different IFIs and transplant type, this paper includes the main recommendations based on previous publications and on the opinion of the authors on the prophylaxis and treatment of these patients. These recommendations highlight epidemiology changes and the emergence of new antifungals. The current document has focused mainly on Candidaspp. and Aspergillusspp., with a special mention to the rest of yeasts and moulds that are common in SOT.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antifungal Agents / administration & dosage
  • Antifungal Agents / therapeutic use
  • Aspergillosis / diagnosis
  • Aspergillosis / drug therapy
  • Aspergillosis / epidemiology
  • Aspergillosis / etiology
  • Aspergillosis / prevention & control
  • Aspergillosis / transmission
  • Candidiasis, Invasive / diagnosis
  • Candidiasis, Invasive / drug therapy
  • Candidiasis, Invasive / epidemiology
  • Candidiasis, Invasive / etiology
  • Candidiasis, Invasive / prevention & control
  • Candidiasis, Invasive / transmission
  • Cohort Studies
  • Cross Infection / diagnosis
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology
  • Cross Infection / etiology
  • Cross Infection / prevention & control
  • Cryptococcosis / diagnosis
  • Cryptococcosis / drug therapy
  • Cryptococcosis / epidemiology
  • Cryptococcosis / etiology
  • Cryptococcosis / prevention & control
  • Cryptococcosis / transmission
  • Drug Interactions
  • Fungemia / diagnosis
  • Fungemia / drug therapy
  • Fungemia / epidemiology
  • Fungemia / etiology*
  • Fungemia / prevention & control
  • Fungemia / transmission
  • Humans
  • Immunocompromised Host
  • Incidence
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / epidemiology
  • Opportunistic Infections / etiology
  • Opportunistic Infections / prevention & control
  • Organ Transplantation* / adverse effects
  • Postoperative Complications / diagnosis
  • Postoperative Complications / drug therapy
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology*
  • Postoperative Complications / prevention & control
  • Practice Guidelines as Topic
  • Premedication
  • Risk

Substances

  • Antifungal Agents